Supplementation Effect of a Combination of Olive (Olea europea L.) Leaf and Fruit Extracts in the Clinical Management of Hypertension and Metabolic Syndrome
[en] Background: The role of herbal products in the prevention of cardiovascular disease requires supporting evidence. This open pilot study assessed the effect of 2-month supplementation of a combination of olive leaf and fruit extracts (Tensiofytol®, Tilman SA, Baillonville, Belgium) in the clinical management of hypertension and metabolic syndrome (MetS). Methods: A total of 663 (pre)-hypertensive patients were enrolled by general practitioners and supplemented for two months with Tensiofytol®, two capsules per day (100 mg/d of oleuropein and 20 mg/d of hydroxytyrosol). Systolic and diastolic blood pressures (SBP/DBP) were measured before and after treatment. Markers of MetS, high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), fasting blood glucose (FG) and waist circumference (WC), were also examined. Results: Significant reductions (p < 0.0001) in SBP/DBP (13 ± 10/7.1 ± 6.6 mmHg) were observed and similarly in pre-diabetic and diabetic patients. Improvements in SBP/DPB were independent of age and gender but greater for elevated baseline SBP/DBP. Tensiofytol® supplementation also significantly improved markers of MetS, with a decrease of TG (11%), WC (1.4%) and FG (4.8%) and an increase of HDL-C (5.3%). Minor side effects were reported in 3.2% patients. Conclusions: This real-life, observational, non-controlled, non-randomized pilot study shows that supplementation of a combination of olive leaf and fruit extracts may be used efficiently and safely in reducing hypertension and MetS markers.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Hermans, Michel; UCLouvain > Institut de Recherche expérimentale et clinique > Service d’Endocrinologie et de Nutrition and Pôle Endocrinologie, Diabète et Nutrition (EDIN),
Lempereur, Philippe; Centre Hospitalier Bois de l’Abbaye > Service de Cardiologie
Salembier, Jean-Paul; CHU UCL Namur - site Sainte-Elisabeth > Service de Cardiologie
MAES, Nathalie ; Centre Hospitalier Universitaire de Liège - CHU > Département de gestion des systèmes d'informations (GSI) > Secteur d'appui à la recherche clinique et biostatistique
Albert, Adelin ; Université de Liège - ULiège > Département des sciences de la santé publique > Département des sciences de la santé publique
Jansen, Olivia ; Université de Liège - ULiège > Département de pharmacie > Pharmacognosie
PINCEMAIL, Joël ; Centre Hospitalier Universitaire de Liège - CHU > Unilab > Laboratoire techniques séparatives et stress oxydant
Language :
English
Title :
Supplementation Effect of a Combination of Olive (Olea europea L.) Leaf and Fruit Extracts in the Clinical Management of Hypertension and Metabolic Syndrome
Grundy, S.M.; Brewer, H.B., Jr.; Cleeman, J.I.; Smith, S.C., Jr.; Lenfant, C. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109, 433–438. [CrossRef]
Vona, R.; Gambardella, L.; Cittadini, C.; Straface, E.; Pietraforte, D. Biomarkers of oxidative stress in metabolic syndrome and associated diseases. Oxid. Med. Cell. Long. 2019. [CrossRef]
Monserrat-Mesquida, M.; Quetglas-Llabres, M.; Capo, X.; Bouzas, C.; Mateos, D.; Pons, A.; Tur, J.A.; Sureda, A. Metabolic syndrome is associated with oxidative stress and proinflammatory state. Antioxidants 2020, 9, 236. [CrossRef]
Lewington, S.; Clarke, R.; Qizilbash, N.; Peto, R.; Collins, R. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360, 1903–1913. [PubMed]
Williams, B.; Mancia, G.; Spiering, W.; Agabiti Rosei, E.; Azizi, M.; Burnier, M.; Clement, D.L.; Coca, A.; de Simone, G.; Dominiczak, A.; et al. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 2018, 39, 3021–3104. [PubMed]
Toledo, E.; Hu, F.B.; Estruch, R.; Buil-Cosiales, P.; Corella, D.; Salas-Salvadó, J.; Covas, M.I.; Arós, F.; Gómez-Gracia, E.; Fiol, M.; et al. Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: Results from a randomized controlled trial. BMC Med. 2013. [CrossRef]
Tuttolomondo, A.; Simonetta, I.; Daidone, M.; Mogavero, A.; Ortello, A.; Pinto, A. Metabolic and vascular effect of the Mediterranean diet. Int. J. Mol. Sci. 2019, 20, 4716. [CrossRef]
Martínez-González, M.A.; Salas-Salvadó, J.; Estruch, R.; Corella, D.; Fitó, M.; Ros, E. Benefits of the Mediterranean diet: Insights from the PREDIMED Study. Progress Cardiovasc. Dis. 2015, 58, 50–60. [CrossRef]
Garcia-Fernandez, E.; Rico-Cabanas, L.; Rosgaard, N.; Estruch, R.; Bach-Faig, A. Mediterranean diet and cardiodiabesity: A review. Nutrients 2014, 6, 3474–3500. [CrossRef]
Hoffman, R.; Gerber, M. Food processing and Mediterranean diet. Nutrients 2015, 7, 7925–7964. [CrossRef]
Guash-Ferré, M.; Merino, J.; Sun, Q.; Fito, M.; Salas-Salvado, J. Dietary polyphenols, Mediterranean diet, prediabetes and type 2 diabetes: A narrative review of the evidence. Oxidative Med. Cell. Long. 2017. [CrossRef] [PubMed]
Guasch-Ferré, M.; Hu, F.B.; Martínez-González, M.A.; Fitó, M.; Bulló, M.; Estruch, R.; Ros, E.; Corella, D.; Recondo, J.; Gómez-Gracia, E.; et al. Olive oil intake and risk of cardiovascular disease and mortality in the PREDIMED Study. BMC Med. 2014. [CrossRef] [PubMed]
Alonso, A.; Martínez-Gonzalez, M.A. Olive oil consumption and reduced incidence of hypertension: The SUN study. Lipids 2004, 39, 1233–1238. [CrossRef] [PubMed]
Bondia-Pons, I.; Schröder, H.; Covas, M.I.; Castellote, A.I.; Kaikkonen, J.; Poulsen, H.E.; Gaddi, A.V.; Machowetz, A.; Kiesewetter, H.; López-Sabater, M.C. Moderate consumption of olive oil by healthy European men reduces systolic blood pressure in non-Mediterranean participants. J. Nutr. 2007, 137, 84–87. [CrossRef]
Moreno-Luna, R.; Muñoz-Hernandez, R.; Miranda, M.L.; Costa, A.F.; Jimenez-Jimenez, L.; Vallejo-Vaz, A.J.; Muriana, F.J.; Villar, J.; Stiefel, P. Olive oil polyphenols decrease blood pressure and improve endothelial function in young women with mild hypertension. Am. J. Hypertens. 2012, 25, 1299–1304. [CrossRef]
Medina-Remón, A.; Tresserra-Rimbau, A.; Pons, A.; Tur, J.A.; Martorell, M.; Ros, E.; Buil-Cosiales, P.; Sacanella, E.; Covas, M.I.; Corella, D.; et al. Effects of total dietary polyphenols on plasma nitric oxide and blood pressure in a high cardiovascular risk cohort. The PREDIMED randomized trial. Nutr. Metab. Cardiovasc. Dis. NMCD 2015, 25, 60–67. [CrossRef]
Ghobadi, S.; Hassanzadeh-Rostami, Z.; Mohammadian, F.; Nikfetrat, A.; Ghasemifard, N.; Dehkordi, R.; Faghih, S. Comparison of blood lipid-lowering effects of olive oil and other plant oils: A systematic review and meta-analysis of 22 randomized placebo-controlled clinical trials. Crit. Rev. Food Sci. Nutr. 2019, 7, 2110–2124. [CrossRef]
Castaner, O.; Fitó, M.; López-Sabater, M.C.; Poulsen, H.E.; Nyyssönen, K.; Schröder, H.; Salonen, J.T.; De la Torre-Carbot, K.; Zunft, H.-F.; De la Torre, R.; et al. The effect of olive oil polyphenols on antibodies against oxidized LDL. A randomized clinical trial. Clin. Nutr. 2011, 30, 490–493. [CrossRef]
Schwingshackl, L.; Christoph, M.; Hoffmann, G. Effects of olive oil on markers of inflammation and endothelial function-A systematic review and meta-analysis. Nutrients 2015, 7, 7651–7675. [CrossRef]
Davis, C.R.; Hodgson, J.M.; Woodman, R.; Bryan, J.; Wilson, C.; Murphy, K.J. Mediterranean diet lowers blood pressure and improves endothelial function: Results from the MedLey randomized intervention trial. Am. J. Clin. Nutr. 2017, 105, 1305–1313. [CrossRef] [PubMed]
Covas, M.I.; Nyyssönen, K.; Poulsen, H.E.; Kaikkonen, J.; Zunft, H.J.; Kiesewetter, H.; Gaddi, A.; de la Torre, R.; Mursu, J.; Bäumler, H.; et al. The effect of polyphenols in olive oil on heart disease risk factors: A randomized trial. Ann. Intern. Med. 2006, 145, 333–341. [CrossRef] [PubMed]
George, E.S.; Marshall, S.; Mayr, H.L.; Trakman, G.L.; Tatucu-Babet, O.A.; Lassemillante, A.M.; Bramley, A.; Reddy, A.J.; Forsyth, A.; Tierney, A.C.; et al. The effect of high-polyphenol extra virgin olive oil on cardiovascular risk factors: A systematic review and meta-analysis. Crit. Rev. Food Sci. Nutr. 2019, 59, 2772–2795. [CrossRef] [PubMed]
Schwingshackl, L.; Lampousi, A.M.; Portillo, M.P.; Romaguera, D.; Hoffmann, G.; Boeing, H. Olive oil in the prevention and management of type 2 diabetes mellitus: A systematic review and meta-analysis of cohort studies and intervention trials. Nutr. Diabetes 2017. [CrossRef]
Omar, S.H. Oleuropein in olive and its pharmacological effects. Sci. Pharm. 2010, 78, 133–154. [CrossRef]
Bulotta, S.; Celano, M.; Lepore, S.M.; Montalcini, T.; Pujia, A.; Russo, D. Beneficial effects of the olive oil phenolic components oleuropein and hydroxytyrosol: Focus on protection against cardiovascular and metabolic diseases. J. Transl. Med. 2014, 12, 219. [CrossRef]
Cherif, S.; Rahal, N.; Haouala, M.; Hizaoui, B.; Dargouth, F.; Gueddiche, M.; Kallel, Z.; Balansard, G.; Boukef, K. A clinical trial of a titrated Olea extract in the treatment of essential arterial hypertension. J. Pharm. Belg. 1996, 51, 69–71. (In French)
Perrinjaquet-Moccetti, T.; Busjahn, A.; Schmidlin, C.; Schmidt, A.; Bradl, B.; Aydogan, C. Food Supplementation with an Olive (Olea europaea L.) Leaf extract reduces blood pressure in borderline hypertensive monozygotic twins. Phytother. Res. 2008, 22, 1239–1242. [CrossRef]
Susalit, E.; Agus, N.; Effendi, I.; Tjandrawinata, R.R.; Nofiarny, D.; Perrinjaquet-Moccetti, T.; Verbruggen, M. Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: Comparison with Captopril. Phytomedicine: Int. J. Phytother. Phytopharm. 2011, 18, 251–258. [CrossRef]
Cabrera-Vique, C.; Navarro-Alarcón, M.; Rodríguez Martínez, C.; Fonollá-Joya, J. Hypotensive effect of an extract of bioactive compounds of olive leaves: Preliminary clinical study. Nutr. Hosp. 2015, 32, 242–249. (In Spanish)
Lockyer, S.; Rowland, I.; Spencer, J.P.; Yaqoob, P.; Stonehouse, W. Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: A randomised controlled trial. Eur. J. Nutr. 2017, 56, 1421–1432. [CrossRef] [PubMed]
Widmer, R.J.; Freund, M.A.; Flammer, A.J.; Sexton, J.; Lennon, R.; Romani, A.; Mulinacci, N.; Vinceri, F.F.; Lerman, L.O.; Lerman, A. Beneficial effects of polyphenol-rich olive oil in patients with early atherosclerosis. Eur. J. Nutr. 2013, 52, 1223–1231. [CrossRef] [PubMed]
Valls, R.M.; Farràs, M.; Suárez, M.; Fernández-Castillejo, S.; Fitó, M.; Konstantinidou, V.; Fuentes, F.; López-Miranda, J.; Giralt, M.; Covas, M.I.; et al. Effects of functional olive oil enriched with its own phenolic compounds on endothelial function in hypertensive patients. A randomised controlled trial. Food Chem. 2015, 167, 30–35. [CrossRef] [PubMed]
Moerland, M.; Kales, A.J.; Schrier, L.; van Dongen, M.G.J.; Bradnock, D.; Burggraaf, J. Evaluation of the EndoPAT as a tool to assess endothelial function. Int. J. Vasc. Med. 2012. [CrossRef]
Verhoeven, V.; Van der Auwera, A.; Van Gaal, L.; Remmen, R.; Apers, S.; Stalpaert, M.; Wens, J.; Hermans, N. Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: A double blind, placebo controlled randomized trial. BMC Complementary Altern. Med. 2015. [CrossRef]
Tshongo Muhindo, C.; Ahn, S.A.; Rousseau, M.F.; Dierckxsens, Y.; Hermans, M.P. Effect and safety of a combination of red yeast rice and olive extract in hypercholesterolemic patients with and without statin-associated myalgia. Complementary Ther. Med. 2017, 35, 140–144. [CrossRef]
Hernáez, Á.; Castañer, O.; losua, R.; Pintó, X.; Estruch, R.; Salas-Salvadó, J.; Corella, D.; Arós, F.; Serra-Majem, L.; Fiol, M.; et al. Mediterranean diet improves high-density lipoprotein function in high-cardiovascular-risk individuals: A randomized controlled trial. Circulation 2017, 135, 633–643. [CrossRef]
Mahdy Ali, K.; Wonnerth, A.; Huber, K.; Wojta, J. Cardiovascular disease risk reduction by raising HDL cholesterol–current therapies and future opportunities. Br. J. Pharmacol. 2012, 167, 1177–1194.
Guasch-Ferré, M.; Hruby, A.; Salas-Salvadó, J.; Martínez-González, M.A.; Sun, Q.; Willett, W.C.; Hu, F.B. Olive oil consumption and risk of type 2 diabetes in US women. Am. J. Clin. Nutr. 2015, 102, 479–486. [CrossRef]
Wainstein, J.; Ganz, T.; Boaz, M.; Bar Dayan, Y.; Dolev, E.; Kerem, Z.; Madar, Z. Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats. J. Med. Food 2012, 15, 605–610. [CrossRef]
De Bock, M.; Derraik, J.G.; Brennan, C.M.; Biggs, J.B.; Morgan, P.E.; Hodgkinson, S.C.; Hofman, P.L.; Cutfield, W.S. Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: A randomized, placebo-controlled, crossover trial. PLoS ONE 2013, 8, e57622. [CrossRef]
Robles-Almazan, M.; Pulido-Moran, M.; Moreno-Fernandez, J.; Ramirez-Tortosa, C.; Rodriguez-Garcia, C.; Quiles, J.L. Hydroxytyrosol: Bioavailability, toxicity and clinical applications. Food Res. Int. 2018, 105, 654–667. [CrossRef] [PubMed]
Colica, C.; Di Renzo, L.; Trombetta, D.; Smerriglio, A.; Bernardini, S.; Cioccoloni, G.; de Miranda, R.C.; Gualtieri, P.; Salimei, P.S.; De Lorenzo, A. Antoxidant effects of a hydroxytyrosol-based pharmaceutical formulation on body composition, metabolic state and gene expression: A randomized double-blinded, placebo-controlled crossover trial. Oxidat. Med. Cell. Long. 2017. [CrossRef] [PubMed]
Garcia-Villalba, R.; Larrosa, M.; Possemiers, S.; Tomas-Barberan, F.A.; Espin, J.C. Bioavailability of phenolics from an oleuropein-rich olive (Olea europea) leaf extract and its acute effect on plasma antioxidant status: Comparison between pre-and postmenopausal women. Eur. J. Nutr. 2014. [CrossRef] [PubMed]
Berrougui, H.; Ikhlef, S.; Khalil, A. Extra virgin oil polyphenols promote cholesterol efflux and improve HDL functionality. Evid.-Based Complem. Altern. Med. 2015. [CrossRef]
Garcia-Villaba, R.; Carrasco-Pancorbo, A.; Nevedomskaya, E.; Mayboroda, O.A.; Deelder, A.M.; Segura-Carretero, A.; Fernandez-Gutierrez, A. Exploratory analysis of human urine by LC-ESI-TOF MS after intake of olive oil: Understanding the metabolism of phenols. Anal. Bioanal. Chem. 2010, 398, 463–475. [CrossRef]
Miro-Casas, E.; Covas, M.-I.; Farre, M.; Fito, M.; Ortuno, J.; Weinbrenner, T.; Roset, P.; de la Torre, R. Hydroxytyrosol disposition in humans. Clin. Chem. 2003, 49, 945–952. [CrossRef]
Pastor, A.; Rodriguez-Morato, J.; Olesti, E.; Pujadas, M.; Perez-Mana, C.; Khymenets, O.; Fito, M.; Covas, M.-I.; Sola, R.; Motilva, M.-J.; et al. Analysis of free hydroxytyrosol in human plasma following the administration of olive oil. J. Chromat. A 2016, 1437, 183–190. [CrossRef]
Markovic, A.K.; Toric, J.; Barbaric, M.; Jakobusic Brala, C. Hydroxytyrosol, tyrosol and derivatives and their potential effects on human health. Molecules 2019, 24, 2001. [CrossRef] [PubMed]
Pourova, J.; Najmanova, I.; Voprsalova, M.; Migkos, T.; Pilarova, V.; Applova, L.; Novakova, L.; Mladenka, P. Two flavonoid metabolites, 3,4 dihydroxyphenylacetic acid and 4-methylcatechol, relax arteries ex vivo and decrease blood pressure in vivo. Vasc. Pharm. 2018, 111, 36–43. [CrossRef]
Khymenets, O.; Fito, M.; Tourino, S.; Munoz-Aguayo, D.; Pujadas, M.; Torres, J.L.; Joglar, J.; Farre, M.; Covas, M.-I.; de la Torre, R. Antioxidant activities of hydroxytyrosol main metabolites do not contribute to beneficial effects after olive ingestion. Drug. Met. Dis. 2010, 38, 1417–1421. [CrossRef] [PubMed]
Birringer, M. Hormetics: Dietary triggers of an adaptive stress response. Pharmacol. Res. 2011, 28, 2680–2694. [CrossRef]
Zhou, Y.; Jiang, Z.; Lu, H.; Xu, Z.; Tong, R.; Shi, J.; Jia, G. Recent advances of natural polyphenols activators for Keap1-Nrf2 signaling pathway. Chem. Biodivers. 2020. [CrossRef]
Martinez-Huelamo, M.; Rodriguez-Morato, J.; Boronat, A. Modulation of NrF2 by olive oil and wine polyphenols and neuroprotection. Antioxidants 2017, 6, 73. [CrossRef] [PubMed]
Martin, M.A.; Ramos, S.; Granado-Serrano, A.B.; Rodriguez-Ramiro, I. Hydroxytyrosol induces antioxidant/detoxificant enzymes and Nrf2 translocation via extracellular regulated kinases and phosphatidylinositol-3-kinase/protein kinase B pathways in HepG2 cells. Mol. Nutr. Food Res. 2010, 54, 956–966. [CrossRef]
Serreli, G.; Deiana, M. Extra olive oil polyphenols: Modulation of cellular pathways related to oxidant species and inflammation in aging. Cells 2020, 9, 478. [CrossRef]
Chartoumpekis, D.V.; Kensler, T.W. New player on an old field: The Keap1/NrF2 pathway as a target for treatment of type 2 diabetes and metabolic syndrome. Curr. Diab. Rev. 2013, 9, 137–145. [CrossRef]
Tran, V.; De Silva, M.; Sobey, C.G.; Lim, K.; Drummond, G.R.; Vinh, A.; Jelinic, M. The vascular consequences of metabolic syndrome: Rodent models, endothelial dysfunction, and current therapies. Front. Pharmacol. 2020. [CrossRef] [PubMed]
Wang, W.; Shang, C.; Zhang, W.; Jin, Z.; Yao, F.; He, Y.; Wang, B.; Li, Y.; Zhang, J.; Lin, R. Hydroxytyrosol NO regulates oxidative stress and NO production through SIRT1 in diabetic mice and vascular endothelial cells. Phytomedicine 2019, 52, 206–215. [CrossRef] [PubMed]
Romero, M.; Toral, M.; Gomez-Guzman, M.; Jimenez, R.; Galindo, P.; Sanchez, M.; Olivares, M.; Galvez, J.; Duarte, J. Antihypertensive effects of oleuropein-enriched olive oil extract in spontaneously hypertensive rats. Food Funct. 2016, 7, 584–593. [CrossRef] [PubMed]
Schmitt, C.A.; Handler, N.; Heiss, E.H.; Erker, T.; Dirsch, V.M. No evidence for modulation of endothelial nitric oxide synthase by the olive oil polyphenol hydroxytyrosol in human endothelial cells. Atherosclerosis 2007, 195, e58–e64. [CrossRef] [PubMed]
Steven, S.; Frenis, K.; Kalinovic, S.; Kuntic, M.; Jimenez, J.T.; Vujacic-Mirski, K.; Helmstädter, J.; Kröller-Schön, S.; Münzel, T.; Daiber, A. Vascular inflammation and oxidative stress: Major triggers for cardiovascular disease. Oxid. Med. Cell. Long. 2019. [CrossRef]
Zou, L.; Prather, E.R.; Steskiv, M.; Garrison, D.E.; Peace, M.T.I.; Zhou, T. Inflammaging and oxidative Stress in human diseases: From molecular mechanisms to novel treatments. Int. J. Mol. Sci. 2019, 20, 4472. [CrossRef]
Barrows, I.R.; Ramezani, A.; Raj, D.S. Inflammation, immunity and oxidative stress in hypertension-partners in crime? Adv. Chron. Kidney Dis. 2019, 26, 122–130. [CrossRef]
Touyz, R.M.; Rios, F.J.; Alves-Lopes, R.; Neves, K.B.; Camargo, L.L.; Montezano, A.C. Oxidative stress: A unifying paradigm in hypertension. Canad. J. Cardiol. 2020, 36, 659–670. [CrossRef]
Richard, N.; Arnold, S.; Hoeller, U.; Lilpert, C. Hydroxytyrosol is the major anti-inflammatory compound in aqueous olive extracts and impairs cytokine and chemokine production in macrophages. Planta Med. 2011, 77, 1890–1897. [CrossRef] [PubMed]
Fucelli, R.; Fabiani, R.; Rosignoli, P. Hydroxytyrosol exerts anti-inflammatory and antioxidant activities in a mouse model of systemic inflammation. Molecules 2018, 23, 3212. [CrossRef]
Ansseau, M.; Seidel, L.; Crosser, A.; Dierckxsens, Y.; Albert, A. A dry extract of Passiflora incarnate L. (Sedanxio®) as first intention treatment of patients consulting for anxiety problems in general practice. Acta Psychiatr. Belg. 2012, 112, 5–11.
Appelboom, T.; Maes, N.; Albert, A. A new Curcuma extract (Flexofytol®) in osteoarthritis: Results from Belgian real-life experience. Open Rheumatol. J. 2014, 8, 77–81. [CrossRef]
Di Ciaula, A.; Portincasa, P.; Maes, N.; Albert, A. Efficacy of bio-optimized extracts of turmeric and essential fennel oil on the quality of life in patients with irritable bowel syndrome. Ann. Gastroenterol. 2018, 31, 685. [CrossRef]
